Impairment of PAR-2-mediated relaxation system in colonic smooth muscle after intestinal inflammation

Impairment of PAR-2-mediated relaxation system in colonic smooth muscle after intestinal inflammation
复制标题

DOI:
10.1038/sj.bjp.0706717
复制
发表时间:
2006-05-01
影响因子:
7.3
通讯作者:
Nasu, Tetsuyuki
Nasu, Tetsuyuki
中科院分区:
医学2区
文献类型:
--
作者:
Sato, Koichi;Ninomiya, Hiromichi;Nasu, Tetsuyuki

文献摘要

被引文献

相似文献

1蛋白酶激活受体(PAR)-2在肠道炎症反应中起重要作用。PAR-2介导的平滑肌功能的变化可能在病理生理学上导致炎症性肠病(IBD)中经常观察到的肠动力障碍。2正常大鼠结肠平滑肌中,胰蛋白酶诱导的卡巴胆碱和KCl诱导的收缩松弛对PAR-2的刺激可通过apamin组织预处理完全解决,但不能通过l-NMMA或神经元阻滞剂混合物预处理解决(河豚毒素、六烃季铵和普萘洛尔)。3在葡聚糖硫酸钠(DSS)引起的结肠炎症中,胰蛋白酶诱导的抑制作用显著降低。在DSS处理的大鼠结肠中,SLIGRL-NH 2(一种选择性PAR-2激活肽)诱导的舒张也减少。然而,1-乙基苯并咪唑啉-2-酮(一种小电导Ca 2+激活的K+通道的激活剂)的抑制作用不受影响。4 DSS处理大鼠结肠外肌层中PAR-2 mRNA的表达显著低于对照大鼠。5这些结果表明,在该实验性结肠炎大鼠模型中,结肠平滑肌中PAR-2介导的舒张系统受到抑制,并可能导致IBD中的运动障碍。
1 Protease-activated receptor (PAR)-2 plays important roles in intestinal inflammatory responses. Changes in PAR-2-mediated smooth muscle function may contribute pathophysiologically to the intestinal motility disorders often observed in inflammatory bowel disease (IBD).2 Stimulation of PAR-2 by trypsin-induced relaxation of carbachol- and KCl-induced contractions in normal rat colonic smooth muscle was completely resolved by tissue pretreatment with apamin, but not by pretreatment with l-NMMA or a cocktail of neuronal blockers (tetrodotoxin, hexamethonium and propranolol).3 In colon inflamed by dextran sodium sulphate (DSS), trypsin-induced inhibitory effects were significantly reduced. Relaxation induced by SLIGRL-NH2, a selective PAR-2-activating peptide, was also reduced in DSS-treated rat colon. However, inhibitory effects of 1-ethylbenzimidazolin-2-one, an activator of small conductance Ca2+-activated K+ channel, were unaffected.4 Expression of PAR-2 mRNA in colonic muscularis externa was significantly lower in DSS-treated rats than in control rats.5 These results suggest that the PAR-2 mediated relaxation system in colonic smooth muscle is suppressed in this experimental colitis rat model, and may contribute to motility disorders in IBD.